Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 9.930 | ||
| Révision: | $2.59B | $2.21B | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 8.100 | 11.770 | 3.6700 |
| Révision: | $1.89B | $2.03B | $1.35B |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 6.040 | 8.330 | 2.2900 |
| Révision: | $1.92B | $1.29B | -$84.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 7.490 | 8.790 | 1.3000 |
| Révision: | $1.92B | $866.97M | -$66.77M |
